Medical Disclaimer

All content on this website, including text, graphics, images, testimonials, and information from our eligibility quiz, is provided for general informational and marketing purposes only. It is not intended to be, and should not be taken as, medical advice, diagnosis, or treatment. Nothing on this website creates a doctor-patient relationship between you and Ongo, or between you and any Provider, until you have completed an evaluation with a licensed healthcare provider through our platform and that provider has agreed to treat you.

Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition, and before starting, stopping, or changing any medication or treatment, including any medication offered through Ongo Weight Loss.

Some medications offered through Ongo Weight Loss Program, including compounded semaglutide and compounded tirzepatide, are compounded medications, not FDA-approved finished drug products.

Compounded drugs are not reviewed or approved by the FDA for safety, effectiveness, or quality before they reach you.

Compounded medications are not the same as, and are not generic versions of, FDA-approved brand-name medications such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. They may differ in formulation, inactive ingredients, dosing, and manufacturing process.

Compounded medications are prepared by a state-licensed pharmacy for an individual patient pursuant to a valid, individualized prescription issued by your Provider, based on their independent clinical judgment that a compounded medication is appropriate for you.

We do not claim, and you should not assume, that a compounded medication offered through Ongo Weight Loss is identical, equivalent, or interchangeable with any FDA-approved medication.

Whether a compounded medication is appropriate for you is a clinical decision made by your Provider, not a decision made by Ongo Weight Loss, and not guaranteed by anything on this website.

We encourage you to discuss the risks, benefits, and appropriateness of any medication, including compounded products, with your Provider before use, and to review current FDA guidance on compounded GLP-1 medications, available at fda.gov.

Completing our eligibility quiz or intake questionnaire does not guarantee that you will be prescribed any medication. Prescribing decisions are made solely by your Provider, based on their independent clinical judgment.

Weight-loss results vary significantly from person to person and depend on many factors, including your individual health, adherence to your treatment plan, diet, and activity level. We do not guarantee any specific weight-loss result, timeline, or outcome.

Any testimonials, before-and-after photos, or reviews on this website reflect individual experiences and are not a guarantee that you will have a similar result.

Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers. Ongo is not affiliated with, sponsored by, or endorsed by the manufacturers of these products. References to these brand names are for informational and comparison purposes only.

This website and our telehealth services are not intended for medical emergencies. If you are experiencing a medical emergency, call 911 immediately. If you are experiencing a mental health crisis, including thoughts of suicide, call or text 988 (Suicide & Crisis Lifeline).

If you experience a side effect or adverse reaction to any medication received through Ongo, contact your Provider promptly. You may also report adverse events directly to the FDA's MedWatch program at 1-800-FDA-1088 or fda.gov/medwatch.

If you have questions about this Medical Disclaimer, contact us at info@ongoweightloss.com or 1-888-655-5267.